Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells.
Della Corte CM, Ciaramella V, Di Mauro C, Castellone MD, Papaccio F, Fasano M, Sasso FC, Martinelli E, Troiani T, De Vita F, Orditura M, Bianco R, Ciardiello F, Morgillo F. Della Corte CM, et al. Among authors: orditura m. Oncotarget. 2016 Jan 26;7(4):4265-78. doi: 10.18632/oncotarget.6559. Oncotarget. 2016. PMID: 26673006 Free PMC article.
The role of EGFR inhibitors in nonsmall cell lung cancer.
Ciardiello F, De Vita F, Orditura M, Tortora G. Ciardiello F, et al. Among authors: orditura m. Curr Opin Oncol. 2004 Mar;16(2):130-5. doi: 10.1097/00001622-200403000-00008. Curr Opin Oncol. 2004. PMID: 15075904 Review.
Synergistic antitumor activity of sorafenib in combination with epidermal growth factor receptor inhibitors in colorectal and lung cancer cells.
Martinelli E, Troiani T, Morgillo F, Rodolico G, Vitagliano D, Morelli MP, Tuccillo C, Vecchione L, Capasso A, Orditura M, De Vita F, Eckhardt SG, Santoro M, Berrino L, Ciardiello F. Martinelli E, et al. Among authors: orditura m. Clin Cancer Res. 2010 Oct 15;16(20):4990-5001. doi: 10.1158/1078-0432.CCR-10-0923. Epub 2010 Sep 1. Clin Cancer Res. 2010. PMID: 20810384 Free article.
Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines.
Morgillo F, Sasso FC, Della Corte CM, Vitagliano D, D'Aiuto E, Troiani T, Martinelli E, De Vita F, Orditura M, De Palma R, Ciardiello F. Morgillo F, et al. Among authors: orditura m. Clin Cancer Res. 2013 Jul 1;19(13):3508-19. doi: 10.1158/1078-0432.CCR-12-2777. Epub 2013 May 21. Clin Cancer Res. 2013. PMID: 23695170
Phosphatidylinositol 3-kinase (PI3Kα)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells.
Morgillo F, Della Corte CM, Diana A, Mauro CD, Ciaramella V, Barra G, Belli V, Franzese E, Bianco R, Maiello E, de Vita F, Ciardiello F, Orditura M. Morgillo F, et al. Among authors: orditura m. Oncotarget. 2017 Aug 22;8(44):76479-76491. doi: 10.18632/oncotarget.20385. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100327 Free PMC article.
Novel investigational drugs for gastric cancer.
Vecchione L, Orditura M, Ciardiello F, De Vita F. Vecchione L, et al. Among authors: orditura m. Expert Opin Investig Drugs. 2009 Jul;18(7):945-55. doi: 10.1517/13543780902969455. Expert Opin Investig Drugs. 2009. PMID: 19466878 Review.
Targeting EGFR in pancreatic cancer treatment.
Troiani T, Martinelli E, Capasso A, Morgillo F, Orditura M, De Vita F, Ciardiello F. Troiani T, et al. Among authors: orditura m. Curr Drug Targets. 2012 Jun;13(6):802-10. doi: 10.2174/138945012800564158. Curr Drug Targets. 2012. PMID: 22458527 Review.
181 results